BSGCT is pleased to continue its partnership with Mary Ann Liebert, Inc., publishers of Human Gene Therapy

Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes important advances in DNA, RNA, cell and immune therapies, validating the latest advances in research and new technologies.

Established in 1990, HGT provides a prestigious forum for publishing scientific and clinical research, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.

HGT is published 12 times per year, including sections on Methods (product testing and development) and Clinical Development (regulatory review, toxicology and commercial development). The journal also publishes a wide range of reviews, commentaries and editorials.

BSGCT members can access the Journal via the member website, and we encourage members to recommend Human Gene Therapy to their library or institution to facilitate collaboration with colleagues.

The Journal welcomes your manuscript submissions. All accepted papers are published online ahead of print.

Latest Impact Factor: * 5.695

*2020 Journal Citation Reports (Clarivate, 2020)

CiteScore™:  7.7


Access Human Gene Therapy

BSGCT members can get free access to the by logging in to your membership account. Under MEMBER AREA select Human Gene Therapy.

BSGCT is pleased to announce its partnership with Mary Ann Liebert, Inc., publishers of Stem Cells and Development

Stem Cells and Development is globally recognized as the trusted source for critical coverage of emerging hypotheses and novel findings. With a focus on stem cells of all types and their role in normal development as well as therapeutic applications, the Journal provides clinical, basic, and translational scientists with cutting-edge research and findings. The influence of stem cell research affects a broad range of science domains. Stem Cells and Development provides an all-encompassing view of the many hypotheses, discoveries, and applications being developed that promise to impact these domains and advance science in a multitude of possible ways. Read a free issue of the Journal online.

The Journal is led by a world-renowned Editorial Board with Editor-in-Chief Graham C. Parker, PhD, at the helm and Senior Editor Hal E. Broxmeyer, PhD.

BSGCT members can visit Stem Cells and Development via the website to view the tables of content and abstracts online. We encourage members to recommend the Journal to their library or institution to facilitate collaboration with colleagues. In addition, all BSGCT members are given the option to receive Genetic Engineering & Biotechnology News on a complimentary basis by filling out a simple qualification form.

The Journal welcomes your manuscript submissions. All accepted papers are published online ahead of print.

Latest Impact Factor* is 3.727
*2014 Journal Citation Reports® published by Thomson Reuters, 2015